Erik Gordon, a professor at the Ross School of Business, discusses how $50 billion in settlement offers by drugmakers and distributors has sparked a fight between state attorneys general and thousands of local governments over how much the pharmaceutical industry should pay for its role in creating the U.S. opioid epidemic. He speaks to Bloomberg’s June Grasso.